These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
751 related articles for article (PubMed ID: 17666042)
1. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation. Levi O; Dolev I; Belinson H; Michaelson DM J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042 [TBL] [Abstract][Full Text] [Related]
2. Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. Levi O; Michaelson DM J Neurochem; 2007 Jan; 100(1):202-10. PubMed ID: 17074063 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related]
4. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Dolev I; Michaelson DM Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176 [TBL] [Abstract][Full Text] [Related]
5. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899 [TBL] [Abstract][Full Text] [Related]
6. Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade. Inbar D; Belinson H; Rosenman H; Michaelson DM Neurodegener Dis; 2010; 7(1-3):16-23. PubMed ID: 20160452 [TBL] [Abstract][Full Text] [Related]
7. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [TBL] [Abstract][Full Text] [Related]
8. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Fagan AM; Watson M; Parsadanian M; Bales KR; Paul SM; Holtzman DM Neurobiol Dis; 2002 Apr; 9(3):305-18. PubMed ID: 11950276 [TBL] [Abstract][Full Text] [Related]
9. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. Huang Y Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952 [TBL] [Abstract][Full Text] [Related]
10. Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4. Levi O; Jongen-Relo AL; Feldon J; Michaelson DM J Neurol Sci; 2005 Mar; 229-230():241-8. PubMed ID: 15760646 [TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
12. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S; Abraham CR; Zannis VI Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639 [TBL] [Abstract][Full Text] [Related]
13. Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation. Levi O; Lütjohann D; Devir A; von Bergmann K; Hartmann T; Michaelson DM J Neurochem; 2005 Nov; 95(4):987-97. PubMed ID: 16190879 [TBL] [Abstract][Full Text] [Related]
14. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242 [TBL] [Abstract][Full Text] [Related]
16. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease. Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538 [TBL] [Abstract][Full Text] [Related]
17. Pathological synergism between amyloid-beta and apolipoprotein E4--the most prevalent yet understudied genetic risk factor for Alzheimer's disease. Belinson H; Michaelson DM J Alzheimers Dis; 2009; 17(3):469-81. PubMed ID: 19363257 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death. Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483 [TBL] [Abstract][Full Text] [Related]
19. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Fagan AM; Holtzman DM Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation. Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]